Leukemia Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 1 | Results 1 - 5 of 5

A Randomized Phase Iii Study Of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib Alone In Untreated Older Patients (¡ý 65 Years Of Age) With Chronic Lymphocytic Leukemia (CLL)

The purpose of this study is to compare the effects, good and/or bad, of the drug ibrutinib, either alone or in combination with the drug rituximab, with the standard treatment for this disease.

Lead Researcher: Syed Ali, MD

Condition/Disease: Cancer - Leukemia

Location:

D’Amour Center for Cancer Care

3350 Main Street

Springfield MA 01199

Franklin Medical Center

164 High Street

Greenfield MA

A phase II trial to study rare tumors

Lead Researcher: John McCann, MD

Condition/Disease: Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

Location:

D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

Baystate Franklin Medical Center
164 High Street
Greenfield, MA 01301

A phase III trial to combine the effects of a group of medications with another combination in patients with newly diagnosed Symptomatic Multiple Myeloma

The purpose of this study is to compare the effects, good and/or bad, of a combination of carfilzomib, lenalidomide and dexamethasone with another combination of bortezomib, lenalidomide and dexamethasone.

Lead Researcher: Syed Ali, MD

Condition/Disease: Cancer - Leukemia, Cancer

Location:

D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

A phase III trial to evaluate different chemotherapies in younger patients with Chronic Lymphocytic Leukemia

The purpose of this study is to compare the effects, good and/or bad, of two different therapies that include combinations of the drugs rituximab, fludarabine, cyclophosphamide and Ibrutinib.

Lead Researcher: Syed Ali, MD

Condition/Disease: Cancer - Leukemia, Cancer

Location:

D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA

Baystate Franklin Medical Center
164 High Street
Greenfield, MA

Molecular Analysis for Therapy Choice (MATCH)

Lead Researcher: John McCann, MD

Location:

D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

Page 1 of 1 | Results 1 - 5 of 5